Aethlon Medical, Inc. (AEMD) Stock Forecast
AEMD analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.00 / 5 from 2 analysts
- Price target
- $13.25 average of analyst targets
- Upside to target
- +157.3% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $-2.91
- 52-week range
- $1.43 – $28.75
AEMD analyst ratings
2 analystsNumber of analysts at each rating.
AEMD price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
AEMD earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$2.90 | −$3.64 | −$2.17 | −$18.70 | +84.5% | 2 |
| Next quarter (Dec '26) | −$1.15 | −$2.17 | −$0.12 | −$12.25 | +90.6% | 2 |
| Current fiscal year (FY2027) | −$5.74 | −$10.55 | −$0.92 | −$53.05 | +89.2% | 2 |
| Next fiscal year (FY2028) | −$0.57 | −$0.57 | −$0.57 | −$5.74 | +90.1% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
AEMD revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 3 |
| Next quarter (Dec '26) | $0 | $0 | $0 | 0.0% | 3 |
| Current fiscal year (FY2027) | $0 | $0 | $0 | 0.0% | 3 |
| Next fiscal year (FY2028) | $0 | $0 | $0 | 0.0% | 2 |
AEMD EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
AEMD EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$1.20 | −$4.05 | −$4.05 | −$4.05 | −$2.90 | +142.1% | 1 up · 0 down |
| Next quarter (Dec '26) | −$1.25 | −$4.05 | −$4.05 | −$4.05 | −$1.15 | −8.4% | 1 up · 0 down |
| Current fiscal year (FY2027) | −$4.90 | −$16.15 | −$16.15 | −$16.15 | −$5.74 | +17.0% | 1 up · 0 down |
| Next fiscal year (FY2028) | −$2.50 | −$2.50 | −$2.50 | −$2.50 | −$0.57 | −77.2% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
AEMD earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; AEMD beat in 5 of 12.
What analysts expect from AEMD
2 analysts cover Aethlon Medical; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $13.25, 157.3% above the latest close of $5.15. Analysts expect earnings of −$5.74 per share for FY2027, +89.2% from a year earlier. For FY2028 the average estimate is −$0.57 per share. Aethlon Medical beat the EPS estimate in 5 of the last 12 quarters.
Related: AEMD income statement, AEMD key metrics, AEMD chart. See the AEMD stock overview for the latest quote and news.
AEMD forecast FAQ
What is Aethlon Medical's price target?
The average analyst price target for Aethlon Medical is $13.25, 157.3% above the latest close of $5.15.
Is Aethlon Medical a buy, hold or sell?
Of 2 analysts covering Aethlon Medical, 0 rate it a strong buy, 0 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Aethlon Medical's EPS forecast?
Analysts forecast −$5.74 per share for FY2027 (range −$10.55 to −$0.92); for FY2028 the estimate is −$0.57.
When does Aethlon Medical report earnings?
Aethlon Medical is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 after the market closes; the EPS estimate is $-2.91.
Does Aethlon Medical usually beat earnings estimates?
Aethlon Medical reported EPS at or above the analyst estimate in 5 of the last 12 quarters.